Bill > S882

This bill aims to improve pharmacy access, transparency, and accountability in Medicare Part D prescription drug plans by establishing new requirements for pharmacy benefit managers (PBMs). The legislation requires PBMs to derive income only from bona fide service fees, provide transparent reporting on drug pricing and rebates, and submit detailed annual reports to Medicare about drug coverage, costs, and performance. Starting in 2028, PBMs must allow any willing pharmacy to participate in their networks under reasonable contract terms, with a focus on protecting pharmacies in medically underserved, rural, suburban, and urban areas with limited pharmacy options. The bill introduces an enforcement mechanism where pharmacies can submit allegations about unfair contract terms, and gives the Secretary of Health and Human Services authority to investigate and impose penalties for violations. Additionally, the legislation mandates that PBMs provide detailed information about drug pricing, manufacturer rebates, and their relationships with affiliates, aiming to increase transparency and potentially lower prescription drug costs for Medicare beneficiaries. The bill also requires PBMs to be accountable for their actions and prohibits them from retaliating against pharmacies or entities reporting potential violations.

Budget and Finance

https://www.congress.gov/bill/119th-congress/senate-bill/882/all-info